Patents by Inventor Ofer Yodfat

Ofer Yodfat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200206417
    Abstract: Embodiments of the current disclosure are directed toward systems, devices and methods for diabetes management. In particular, the present disclosure relates to systems, devices and methods for dispensing insulin to a patient using a miniaturized and portable patch pump.
    Type: Application
    Filed: June 15, 2018
    Publication date: July 2, 2020
    Applicant: Triple Jump Israel Ltd.
    Inventors: Ofer YODFAT, Guy SHINAR, Yishai BEN-DAVID
  • Publication number: 20200179594
    Abstract: Embodiments of the current disclosure are directed toward systems, devices and methods for diabetes management. In particular, the present disclosure relates to devices and methods for dispensing insulin to a patient. A portable fluid infusion device, comprising a disposable part (DP) and a reusable part (RP) is disclosed. The DP comprises a first reservoir and a second reservoir, the second reservoir less than or equal to the first reservoir in length, while the RP comprises a first compartment configured to receive the first reservoir, a second compartment configured to receive the second reservoir and a gasket for sealing a junction between the second reservoir and the second compartment upon connection of the RP and the DP.
    Type: Application
    Filed: February 12, 2020
    Publication date: June 11, 2020
    Applicant: Triple Jump Israel Ltd.
    Inventors: Ofer YODFAT, Guy SHINAR, Yishai BEN-DAVID
  • Patent number: 10603432
    Abstract: Disclosed are methods, systems, devices and articles, including a method for adaptive wireless communication transmissions between units of an ambulatory portable medical device. The method includes obtaining data relating to wireless transmissions between the units of the medical device, and setting one or more attributes of wireless transmission of one or more messages between the units of the medical device based, at least in part, on the obtained data.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: March 31, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret, Zohar Man, Tsabar Mor
  • Patent number: 10583244
    Abstract: Embodiments of the current disclosure are directed toward systems, devices and methods for diabetes management. In particular, the present disclosure relates to devices and methods for dispensing insulin to a patient. A portable fluid infusion device, comprising a disposable part (DP) and a reusable part (RP) is disclosed. The DP comprises a first reservoir and a second reservoir, the second reservoir less than or equal to the first reservoir in length, while the RP comprises a first compartment configured to receive the first reservoir, a second compartment configured to receive the second reservoir and a gasket for sealing a junction between the second reservoir and the second compartment upon connection of the RP and the DP.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: March 10, 2020
    Assignee: TRIPLE JUMP ISRAEL LTD.
    Inventors: Ofer Yodfat, Guy Shinar, Yishai Ben-David
  • Patent number: 10531943
    Abstract: Some embodiments of the present disclosure are directed generally to systems and methods for delivering an implant to a body vessel of a patient. Such disclosed implants may be a monofilament implant, and disclosed systems for implanting the implant may be automatic. Some embodiments may enable retraction of said implant back into the delivery system following partial exteriorization of the implant from the delivery system. Some embodiments may be configured for retraction of said implant from the patient's body following complete exteriorization of the implant from the delivery system. Some of the embodiments are directed at delivering a monofilament implant for preventing embolic stroke. Other embodiments are directed at preventing pulmonary embolism, occluding a body vessel such as the left atrial appendage, occluding a body passageway such as a patent foramen ovalae, stenting a body vessel, or releasing a local therapeutic agent such as a drug or ionizing radiation.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: January 14, 2020
    Assignee: JAVELIN MEDICAL LTD.
    Inventors: Yair Dan, Avraham Neta, Guy Shinar, Ofer Yodfat
  • Patent number: 10493203
    Abstract: Devices and methods for powering a medical device for sustained delivery of fluids or continuous monitoring of body analyte are disclosed. The devices may comprise a pumping mechanism, a driving mechanism for activating the pumping mechanism to dispense fluid, and a power source coupled to the driving mechanism and having an energy storage cell for providing a pulsed power to the driving mechanism. The methods may be implemented by activating the driving mechanism using pulsed energy in the form of at least one pulse train pattern accumulated in and discharged from an energy storage component.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: December 3, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret
  • Patent number: 10485937
    Abstract: Disclosed is a dispensing system. The dispensing system includes a dispensing unit to dispense therapeutic fluid, and a validation mechanism to enable operation of the dispensing unit based, at least in part, on a determination of whether operation of the dispensing device is authorized.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: November 26, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret
  • Publication number: 20190343612
    Abstract: Embodiments of the present disclosure are directed to systems, methods and devices for providing embolic protection in a patient. In some embodiments, the device is configured for implantation in a body vessel including fluid flow. The device may assume, or be constrained to assume, an undeployed state and a deployed state. In the undeployed state, the device or a portion thereof has a substantially linear shape configured to reside in the lumen of a thin needle having a diameter of less than about 0.5 mm (for example), in the deployed state, the device has a primary axis. When the device is implanted the primary axis is approximately perpendicular to the fluid flow. In some embodiments, the device comprises a thin filament body. In the deployed state the filament takes a helical shape. Emboli that are larger than the distance between consecutive turns or windings of the helix are thus filtered by the device and are prevented from causing deleterious conditions such as stroke or pulmonary embolism.
    Type: Application
    Filed: February 7, 2019
    Publication date: November 14, 2019
    Applicant: Javelin Medical Ltd.
    Inventors: Guy SHINAR, Ofer YODFAT
  • Patent number: 10434245
    Abstract: Disclosed is a skin securable therapeutic fluid dispensing device that includes a reservoir adapted to retain therapeutic fluid, a pump driving mechanism, and at least one housing configured to accommodate the reservoir and the pump driving mechanism, with at least a portion of the at least one housing defining at least a portion of the reservoir. The device also includes a shield coupled to the at least one housing, the shield configured to protect, at least in part, the reservoir from application of external forces thereon.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: October 8, 2019
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Ofer Arnold, Yair Dan
  • Publication number: 20190269413
    Abstract: Embodiments of the present disclosure are directed to methods, systems and devices for implanting a spatially bent and/or twisted implant in a patient. In some embodiments, such a method includes providing a mono-filament implant configured to assume an undeployed, substantially linear state or linear-like state and a spatially bent and/or twisted deployed state, with the plant having a proximal and a distal end. In the undeployed state, the implant includes a shape which corresponds to that of a lumen of a hollow needle which may be used to deliver the implant. The method may also include creating a puncture in a vessel of the patient and positioning said distal end of the needle (and thus, the implant) in the vessel through the puncture. The method may further include converting the implant from the undeployed state to the deployed state such that the proximal end of the implant is proximate said puncture.
    Type: Application
    Filed: October 5, 2018
    Publication date: September 5, 2019
    Inventors: Ofer YODFAT, Guy SHINAR
  • Patent number: 10398831
    Abstract: Systems, methods and apparatuses for delivering therapeutic fluid to the body of a patient are disclosed. The apparatus includes a dispensing unit having a driving mechanism, a pumping mechanism, a reservoir containing therapeutic fluid, and an outlet port. The driving mechanism causes the pumping mechanism to positively displace therapeutic fluid within the reservoir for delivery of therapeutic fluid to the body of the patient via the outlet port.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: September 3, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avraham Neta, Yossi Shalev
  • Patent number: 10369281
    Abstract: Devices, systems and methods for adjusting fluid delivery based on past or historical fluid delivery data and/or personal parameters of a user are disclosed. Devices, and corresponding systems and methods, may comprise a dispensing unit configured to deliver a fluid from a reservoir into the body of a user and a processor having instructions operating thereon to retrieve data relating to one or more time windows from a memory, assess a correction delivery for the one or more time windows based on the data, determine a new CIR value for the one or more time windows if the correction delivery regularly follows a meal bolus and/or determine a new basal delivery profile for the one or more time windows if the correction delivery regularly precedes a meal bolus.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: August 6, 2019
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Patent number: 10350354
    Abstract: A device and a method for prevention of hypoglycemia are disclosed. In one aspect, the device and the method for prevention of hypoglycemia can comprise receiving a target blood glucose (TBG) level corresponding to a desired level of glucose in a patient's body during a fasting time period; receiving a bedtime blood glucose (BBG) level corresponding to a level of glucose in the patient's body substantially at a beginning of the fasting time period (e.g. before bedtime); receiving a first set of parameters corresponding to a medical state of the patient; determining a therapeutic course of action based on the levels of the TBG, BBG and the medical state of the patent; and administering the therapeutic course of action to the patient.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: July 16, 2019
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Neesha Ramchandani
  • Publication number: 20190192767
    Abstract: Disclosed is an ambulatory therapeutic fluid delivery device. The device includes at least one housing connectable to a cannula, the at least one housing retaining a reservoir to hold the therapeutic fluid. The device also includes a mechanically powered pumping mechanism to cause delivery of at least some of the fluid from the reservoir, and a power-transfer mechanism to transfer manually-delivered power provided by a user to mechanically actuate the pumping mechanism.
    Type: Application
    Filed: February 27, 2019
    Publication date: June 27, 2019
    Inventors: Ofer Yodfat, Gavriel J. Iddan, Illai Gescheit
  • Publication number: 20190167404
    Abstract: Systems, devices and methods are presented for embolic protection. In some embodiments, a device for implantation in a patient's vessel containing a fluid flow is provided which comprises proximal and distal ends, an undeployed, substantially linear state, and a deployed, spring-like (helical) state comprising windings. When the device is deployed, the line segment connecting the proximal and distal ends is approximately perpendicular to the majority of the windings and to the fluid flow. In some embodiments, a delivery device for the monofilament device is provided. The delivery device comprises a needle having a lumen, a sharp distal end, and a pusher slidable within the needle. A method for deploying the monofilament device using the delivery device is provided.
    Type: Application
    Filed: July 23, 2018
    Publication date: June 6, 2019
    Applicant: Javelin Medical Ltd.
    Inventors: Guy SHINAR, Ofer YODFAT
  • Patent number: 10272199
    Abstract: Delivery of more than one therapeutic fluid as a means to control symptoms of a health conditions is disclosed. More than one therapeutic fluid may be dispensed from more than one reservoir and delivered to a user's body via one or more cannula that penetrate the skin. The therapeutic fluids may be delivered by action of one or more pumping mechanisms that may be controlled by a processor in a portable, ambulatory device. The therapeutic fluids may optionally be insulin and one or more of an amylin analog, pramlintide acetate and an exenatide, and the health condition may optionally be diabetes. This device can be used in combination with a glucometer.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: April 30, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gali Shapira
  • Patent number: 10265464
    Abstract: A portable therapeutic fluid delivery device and a method for delivering a therapeutic fluid into a body of a patient are provided. In one aspect the therapeutic fluid delivery device and the method can be implemented using at least one housing securable to the body of the patient, a reservoir coupled to the at least one housing, a therapeutic fluid dispensing mechanism, a memory component, a controller, at least one bolus delivery button configured to signal the controller to initiate the delivery of the therapeutic fluid into the body of the patient; and, an inadvertent initiation prevention mechanism adapted for preventing the patient from activating the at least one bolus delivery button.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: April 23, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Danna Perlman
  • Patent number: 10258737
    Abstract: Disclosed is a skin adherable device for delivering therapeutic fluid into a body of a patient. The device includes a monitoring apparatus, a dispensing apparatus, and a tip for delivering the therapeutic fluid into the body of the patient and for monitoring bodily analyte in the body of the patient. The dispensing apparatus may continuously deliver the therapeutic fluid to the body of the patient and the monitoring apparatus may continuously monitor bodily analytes of the patient.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: April 16, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Ruthy Kaidar
  • Publication number: 20190099551
    Abstract: Embodiments of the current disclosure are directed toward systems, devices and methods for diabetes management. In particular, the present disclosure relates to devices and methods for dispensing insulin to a patient. A portable fluid infusion device, comprising a disposable part (DP) and a reusable part (RP) is disclosed. The DP comprises a first reservoir and a second reservoir, the second reservoir less than or equal to the first reservoir in length, while the RP comprises a first compartment configured to receive the first reservoir, a second compartment configured to receive the second reservoir and a gasket for sealing a junction between the second reservoir and the second compartment upon connection of the RP and the DP.
    Type: Application
    Filed: May 5, 2016
    Publication date: April 4, 2019
    Applicant: TRIPLE JUMP ISRAEL LTD.
    Inventors: Ofer YODFAT, Guy SHINAR, Yishai BEN-DAVID
  • Patent number: 10238795
    Abstract: Disclosed is an ambulatory therapeutic fluid delivery device. The device includes at least one housing connectable to a cannula, the at least one housing retaining a reservoir to hold the therapeutic fluid. The device also includes a mechanically powered pumping mechanism to cause delivery of at least some of the fluid from the reservoir, and a power-transfer mechanism to transfer manually-delivered power provided by a user to mechanically actuate the pumping mechanism.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: March 26, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gavriel J. Iddan, Illai Gescheit